Bccip - BRCA2 and CDKN1A interacting protein

Predicted to enable kinase regulator activity and tubulin binding activity. Predicted to be involved in cellular response to DNA damage stimulus; microtubule cytoskeleton organization; and neuroendocrine cell differentiation. Predicted to act upstream of or within regulation of cyclin-dependent protein serine/threonine kinase activity. Predicted to be located in cytosol; microtubule cytoskeleton; and nucleoplasm. Predicted to be part of nuclear cyclin-dependent protein kinase holoenzyme complex. Predicted to be active in nucleus. Orthologous to human BCCIP (BRCA2 and CDKN1A interacting protein). [provided by Alliance of Genome Resources, Apr 2022]